vimarsana.com
Home
Live Updates
Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy : vimarsana.com
Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy : vimarsana.com
Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy
SEATTLE--(BUSINESS WIRE)--Apr 10, 2024--
Related Keywords
United States ,
Argentina ,
Buenos Aires ,
Distrito Federal ,
James Tumlin ,
Nasdaq ,
Linkedin ,
Alpine Immune Sciences ,
Nephronet Clinical Trials Consortium ,
Buenos Aires Convention Center ,
Exchange Commission ,
Securities Exchange ,
Vertex Pharmaceuticals Incorporated ,
World Congress ,
Alpine Immune Sciences Inc ,
Immune Sciences ,
Clinically Meaningful ,
Iga Nephropathy ,
Business Wire ,
Highlights Include ,
Nephrology Late Breaking ,
Updated Results ,
Enhanced Dual ,
Poster Session ,
Late Breaking ,
Exhibition Hall ,
Main Foyer ,
Emory University School ,
Nephronet Clinical Trials ,
Securities Act ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
Recommendation Statement ,
Investor Relations Contact ,